# Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt

> **NCT07495644** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 95 (estimated)

## Conditions studied

- Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)

## Interventions

- **BIOLOGICAL:** adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab

## Key facts

- **NCT ID:** NCT07495644
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07495644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07495644, "Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07495644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*